{"id":"https://openalex.org/W3211546201","doi":"https://doi.org/10.1182/blood-2021-148049","title":"Matching Adjusted Indirect Comparison (MAIC) of Oral Azacitidine (Oral-AZA) Versus Injectable AZA in Patients (pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy","display_name":"Matching Adjusted Indirect Comparison (MAIC) of Oral Azacitidine (Oral-AZA) Versus Injectable AZA in Patients (pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3211546201","doi":"https://doi.org/10.1182/blood-2021-148049","mag":"3211546201"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-148049","doi":"https://doi.org/10.1182/blood-2021-148049","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-148049","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103581365","display_name":"Clara C. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clara Chen","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033586033","display_name":"Gerwin A Huls","orcid":"https://orcid.org/0009-0001-6789-6433","observed_orcids":["https://orcid.org/0009-0001-6789-6433"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Gerwin A. Huls","raw_affiliation_strings":["Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024264093","display_name":"Heather L. Cameron","orcid":"https://orcid.org/0000-0002-3886-8257","observed_orcids":["https://orcid.org/0000-0002-3886-8257"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Heather Cameron","raw_affiliation_strings":["EVERSANA, Burlington, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001617887","display_name":"Beatrice Suero","orcid":"https://orcid.org/0009-0009-3134-5136","observed_orcids":["https://orcid.org/0009-0009-3134-5136"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Beatrice Suero","raw_affiliation_strings":["EVERSANA, Burlington, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023668101","display_name":"Alberto Vasconcelos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alberto Vasconcelos","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085019642","display_name":"Lona Gaugler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lona Gaugler","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015991333","display_name":"C.L. Beach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.L. Beach","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"3015","last_page":"3015"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-azacitidine","display_name":"oral azacitidine","score":0.9520000219345093},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7829999923706055},{"id":"https://openalex.org/keywords/first-complete-remission","display_name":"first complete remission","score":0.7269999980926514},{"id":"https://openalex.org/keywords/intensive-induction-chemotherapy","display_name":"intensive induction chemotherapy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.7020000219345093},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.921999990940094},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.593999981880188},{"id":"https://openalex.org/keywords/blood-transfusion","display_name":"blood transfusion","score":0.5839999914169312},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.6100000143051147},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.5929999947547913},{"id":"https://openalex.org/keywords/propensity-score","display_name":"propensity score","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8424712419509888},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7141803503036499},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6006802320480347},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.5981040596961975},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5834263563156128},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5163296461105347},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47721391916275024},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4342164397239685},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.416331946849823},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.41249412298202515},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34210261702537537},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08209577202796936},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-148049","doi":"https://doi.org/10.1182/blood-2021-148049","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-148049","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4311203322","https://openalex.org/W3211747437","https://openalex.org/W3097014108","https://openalex.org/W4296468283","https://openalex.org/W3095309665","https://openalex.org/W4360600096","https://openalex.org/W4417009485","https://openalex.org/W4283362445","https://openalex.org/W4404825069","https://openalex.org/W3204185128"],"abstract_inverted_index":{"Abstract":[0],"INTRODUCTION:":[1],"Oral-AZA":[2,37,83,169,193,452,481,504,546,596],"was":[3,49,159,178,362,473],"approved":[4],"in":[5,9,22,199,203,333,360,405,422,539,585,591,629,663,692,704,716],"the":[6,56,88,108,141,164,182,321,366,377,383,386,403,423,433,437,444,469,491,530,627,630],"United":[7],"States":[8],"September":[10],"2020":[11],"for":[12,154,309,328,342,418,451,459,477,569],"continued":[13],"treatment":[14],"(Tx)":[15],"of":[16,110,137,143,212,325,344,368,385,395,436,471,493,535,621],"adult":[17],"patients":[18,478],"(pts)":[19],"with":[20,168,192,201,480,503,545,557,589],"AML":[21,202],"first":[23,204,291,322,592,633],"remission":[24,205,593],"after":[25,206,594],"intensive":[26],"chemotherapy":[27],"(IC).":[28],"The":[29],"phase":[30,57],"3":[31,58],"QUAZAR":[32,228,241,255,315,424],"AML-001":[33,229,242,256,316,425],"trial":[34],"showed":[35,468,542],"that":[36,379,584],"significantly":[38,66,601],"improved":[39,67],"overall":[40],"and":[41,48,84,117,129,186,218,268,283,294,347,374,388,440,498,519,566,571,611,646],"relapse-free":[42],"survival":[43,69],"(OS/RFS)":[44],"vs":[45,70,170,194,408,453,462,482,505],"placebo":[46],"(PBO)":[47],"generally":[50],"well-tolerated":[51],"(Wei,":[52],"NEJM":[53],"2020).":[54],"In":[55,140,302],"HOVON97":[59,251,334,361,438],"trial,":[60],"subcutaneous":[61],"(SC)":[62],"AZA":[63,86,116,172,196,308,330,359,461,484,507,559,617],"maintenance":[64,197,597,618],"Tx":[65,156,372,391,537],"disease-free":[68],"observation,":[71],"but":[72,604],"did":[73,248],"not":[74,94,249,599],"show":[75],"an":[76],"OS":[77,166],"benefit":[78,167],"(Huls,":[79],"Blood":[80],"2019).":[81],"Although":[82],"SC":[85,171,195,307,329,358,460,483,506,558,616],"contain":[87],"same":[89],"active":[90],"drug,":[91],"they":[92],"are":[93,340,547,641],"bioequivalent.":[95],"Oral":[96],"administration":[97,331],"allows":[98],"extended":[99],"exposure":[100,346,538],"to":[101,115,127,162,180,230,232,290,311,320,357,390,443,529,551,576,626,632],"lower":[102],"drug":[103,122,345],"concentrations,":[104],"which":[105,152,541],"could":[106,305],"increase":[107],"number":[109,367],"diseased":[111],"progenitor":[112],"cells":[113],"exposed":[114],"maximize":[118],"therapeutic":[119],"effects":[120],"(eg,":[121],"incorporation":[123],"into":[124],"RNA":[125],"leading":[126],"apoptosis),":[128],"may":[130],"improve":[131],"tolerability":[132],"by":[133,351,475,508,643],"decreasing":[134],"AZA-related":[135],"exacerbations":[136],"existing":[138],"cytopenias.":[139],"absence":[142],"head-to-head":[144],"trials,":[145],"a":[146,246,262,411,607],"matching":[147],"adjusted":[148,269,341,442],"indirect":[149],"comparison":[150],"(MAIC),":[151],"adjusts":[153],"potential":[155],"effect":[157],"modifiers,":[158],"previously":[160],"conducted":[161],"evaluate":[163],"relative":[165,183,353],"(Chen,":[173],"EHA":[174],"2021).":[175],"This":[176],"MAIC":[177,210],"performed":[179,221],"determine":[181],"safety":[184,426,466,609],"profile":[185,610],"health":[187],"care":[188],"resource":[189],"utilization":[190],"(HCRU)":[191],"therapy":[198,598],"pts":[200,304,369,420,543,555,590],"IC.":[207],"METHODS:":[208],"Anchored":[209],"analyses":[211,394,532],"serious":[213],"Tx-emergent":[214],"adverse":[215],"events":[216],"(SAEs)":[217],"HCRU":[219,614],"were":[220,243,259,271,288,318,335,441,455,501,527],"using":[222,261,410],"individual":[223],"pt":[224,247,257],"data":[225,258,582],"(IPD)":[226],"from":[227,237,240,337,574],"match":[231],"baseline":[233],"(BL)":[234],"summary":[235],"statistics":[236],"HOVON97.":[238],"IPD":[239,417],"removed":[244],"when":[245],"meet":[250],"eligibility":[252,434],"criteria.":[253],"Remaining":[254],"weighted":[260],"method-of-moments":[263],"propensity":[264],"score":[265],"model.":[266,415],"Matched":[267],"variables":[270],"BL":[272],"age,":[273],"platelet":[274,295,496],"count,":[275,277],"neutrophil":[276],"ECOG":[278],"performance":[279],"score,":[280],"cytogenetic":[281],"risk,":[282],"response":[284],"status.":[285],"Analysis":[286],"endpoints":[287],"times":[289],"SAE,":[292],"hospitalization,":[293],"or":[296],"red":[297],"blood":[298],"cell":[299],"(RBC)":[300],"transfusion.":[301],"HOVON97,":[303,540],"receive":[306],"up":[310],"12":[312,323],"cycles;":[313],"therefore,":[314],"outcomes":[317],"limited":[319,625,642],"cycles":[324],"Tx.":[326],"Hospitalizations":[327],"only":[332,402,600],"excluded":[336],"analyses.":[338],"Endpoints":[339],"pt-years":[343],"compared":[348],"between":[349],"studies":[350],"calculating":[352],"risks":[354,492,645],"(RR).":[355],"Exposure":[356],"imputed":[363,536],"based":[364],"on":[365,376,636],"entering":[370],"each":[371],"cycle,":[373],"relies":[375],"assumption":[378],"events/censoring":[380],"happened":[381],"at":[382],"end":[384],"cycle":[387],"led":[389],"discontinuation.":[392],"Sensitivity":[393],"model":[396],"robustness":[397],"relaxed":[398],"these":[399],"assumptions,":[400],"comparing":[401],"difference":[404],"cumulative":[406],"hazard":[407,567],"PBO/observation":[409],"cloglog":[412],"link":[413],"binomial":[414],"RESULTS:":[416],"398/469":[419],"(85%)":[421],"population":[427,439],"(Oral-AZA":[428],"n=203,":[429],"PBO":[430,454],"n=195)":[431],"met":[432],"criteria":[435],"comparator.":[445],"For":[446],"all":[447],"endpoints,":[448],"rate":[449,631],"ratios":[450],"less":[456,549,613],"than":[457,554,615],"those":[458],"observation":[463],"(Table).":[464,578],"MAIC-weighted":[465],"comparisons":[467],"risk":[470],"SAEs":[472,553],"reduced":[474,502],"65%":[476],"treated":[479,544,556],"(RR":[485,510,516,521],"0.35":[486],"[95%":[487,512,563],"CI:":[488,513,564],"0.18-0.68]).":[489],"Similarly,":[490],"hospitalization":[494,570],"requirements,":[495],"transfusion,":[497],"RBC":[499],"transfusion":[500],"59%":[509],"0.41":[511],"0.24-0.71),":[514],"54%":[515],"0.46":[517],"[0.23-0.93]),":[518],"47%":[520],"0.53":[522],"[0.28-1.00]),":[523],"respectively.":[524],"All":[525],"findings":[526],"robust":[528],"sensitivity":[531],"relaxing":[533],"assumptions":[534],"70%":[548],"likely":[550],"experience":[552],"(hazard":[560],"ratio:":[561],"0.30":[562],"0.09-1.02]),":[565],"reductions":[568],"transfusions":[572],"ranged":[573],"-51%":[575],"-58%":[577],"CONCLUSIONS":[579],":":[580],"These":[581],"suggest":[583],"controlled":[586],"clinical":[587],"trials":[588],"IC,":[595],"improves":[602],"OS,":[603],"also":[605],"provides":[606],"better":[608],"requires":[612],"therapy.":[619],"Interpretation":[620],"results":[622],"should":[623],"be":[624],"differences":[628],"SAE":[634],"while":[635],"Tx,":[637],"as":[638],"stronger":[639],"generalizations":[640],"competing":[644],"informative":[647],"censoring.":[648],"Figure":[649,651],"1":[650],"1.":[652],"Disclosures":[653],"Chen:":[654],"Bristol":[655,674,679,684,696,708],"Myers":[656,675,680,685,697,709],"Squibb:":[657,676,681,686,698,710],"Current":[658,660,671,687,689,699,701,711,713],"Employment,":[659,688,700,712],"equity":[661,690,702,714],"holder":[662,691,703,715],"publicly-traded":[664,693,705,717],"company.":[665,694,706,718],"Huls:":[666],"Universaity":[667],"Medical":[668],"Center":[669],"Groningen:":[670],"Employment.":[672],"Cameron:":[673],"Consultancy.":[677,682],"Suero:":[678],"Vasconcelos:":[683],"Gaugler:":[695],"Beach:":[707]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2021-11-22T00:00:00"}